TGA Approval

COSENTYX secukinumab (rch) 300 mg/2 mL solution for injection pre-filled syringe (353265)

ARTG ID

353265

ARTG Name

COSENTYX secukinumab (rch) 300 mg/2 mL solution for injection pre-filled syringe

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

February 2, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/7a64729f9257789789292e8f7ecc6537.pdf

Ingredient Name

Secukinumab

Empowering clinical research with data-driven insights and AI-powered tools.

COSENTYX secukinumab (rch) 300 mg/2 mL solution for injection pre-filled syringe (353265) - TGA 批准文号 | MedPath